CoChat

Endothelial ALK1 Is a Therapeutic Target to Block Metastatic Dissemination of Breast Cancer

Cunha, Sara I., Bocci, Matteo, Lövrot, John, Eleftheriou, Nikolas, Roswall, Pernilla, Cordero, Eugenia, Lindström, Linda, Bartoschek, Michael, Haller, B. Kristian, Pearsall, R. Scott, Mulivor, Aaron W., Kumar, Ravindra, Larsson, Christer, Bergh, Jonas, Pietras, Kristian · 2015 · Cancer Research
Cited by 70

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Exploration of new strategies for the prevention of breast cancer metastasis is justifiably at the center of clinical attention. In this study, we combined a computational biology approach with mechanism-based preclinical trials to identify inhibitors of activin-like receptor kinase (ALK) 1 as effective agents for blocking angiogenesis and metastasis in breast cancer. Pharmacologic targeting of ALK1 provided long-term therapeutic benefit in mouse models of mammary carcinoma, accompanied by strikingly reduced metastatic colonization as a monotherapy or part of combinations with chemotherapy. Gene-expression analysis of breast cancer specimens from a population-based nested case–control study encompassing 768 subjects defined endothelial expression of ALK1 as an independent and highly specific prognostic factor for metastatic manifestation, a finding that was corroborated in an independent clinical cohort. Overall, our results suggest that pharmacologic inhibition of endothelial ALK1 constitutes a tractable strategy for interfering with metastatic dissemination of breast cancer. Cancer Res; 75(12); 2445–56. ©2015 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-14-3706

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 70

Metadata

Authors
Cunha, S. I., Bocci, M., Lövrot, J., Eleftheriou, N., Roswall, P., Cordero, E., Lindström, L., Bartoschek, M., Haller, B. K., Pearsall, R. S., Mulivor, A. W., Kumar, R., Larsson, C., Bergh, J., & Pietras, K.
Venue
Cancer Research
Published
2015-06-14
Volume
75
Issue
12
Pages
2445-2456
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W1822908384
Cited by
70
References
7
FWCI
3.77
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Endothelial ALK1 Is a Therapeutic Target to Block Metastatic Dissemination of Breast Cancer. https://app.cochat.ai/papers/10.1158/0008-5472.can-14-3706
The paper
Cunha, S. I., Bocci, M., Lövrot, J., Eleftheriou, N., Roswall, P., Cordero, E., Lindström, L., Bartoschek, M., Haller, B. K., Pearsall, R. S., Mulivor, A. W., Kumar, R., Larsson, C., Bergh, J., & Pietras, K. (2015). Endothelial ALK1 Is a Therapeutic Target to Block Metastatic Dissemination of Breast Cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-14-3706

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.